生体吸収性ポリマー市場 – 2029年までの世界予測

Report Overview

In terms of value, the bioresorbable polymers market is estimated to grow from USD 500.0 million in 2024 to USD 867.2 million by 2029, at a CAGR of 11.6%. Favorable regulations and policies by the government towards healthcare industry are positively influencing the bioresorbable polymers market.

生体吸収性ポリマー市場は、2024 年の 5 億米ドルから 2029 年までに 8 億 6,720 万米ドルに、CAGR 11.6% で成長すると推定されています。医療業界に対する政府による有利な規制と政策は、生体吸収性ポリマー市場にプラスの影響を与えています。

Various countries have created regulations that encourage manufacturers to increase biocompatibility & biodegradability of medical devices like orthopedic devices. These changes promote the creation of bioresorbable polymers. New technologies for the surgical implants are driving the demand for bioresorbable polymers. This further encourages businesses to invest in the bioresorbable polymers market.

“PCL type segment is projected to be the third-fastest growing segment of bioresorbable polymers market, during the forecast period”

PCL type segment is estimated to be the third-fastest growing segment of bioresorbable polymers market, during the forecast period. This demand is primarily due to its demand in drug delivery systems. The properties of biocompatibility and flexibility make PCL flexible and capable for use in any drug delivery format, such as injectable microparticles, implantable devices, and capsules. Compatibility with other bioresorbable polymers brings it as the first choice for customized formulations in advanced therapeutic systems.

“Drug delivery was the second largest end-use industry of bioresorbable polymers market, in terms of value, in 2023.”

Drug delivery segment stands as the second-largest application in the bioresorbable polymers market. The demand is fueled by the need of controlled, targeted, and sustained-release drug systems, resulting in improved patient outcomes. Bioresorbable polymers are also widely employed in the preparation of implantable drug matrices and capsules to provide a slow and controlled release of therapeutic agents over time. This avoids the need for re-dose, thus significantly reducing discomfort to the patient. Their biocompatibility ensures that these polymers degrade safely within the body, well in line with the increasing trend by the medical industry towards innovative, patient-centered care solutions. With the desire for advanced drug delivery systems all over the world on the rise, bioresorbable polymers are among the most important choices when making efficient and effective therapeutic solutions.

“Europe was the second largest region in the bioresorbable polymers market, in terms of value.”

Europe was the second-largest region in the bioresorbable polymers market, in terms of value, in 2023. The bioresorbable polymers market in the region is comparatively mature, growing slower than the developing markets in the Asia-Pacific region and South America. The demand of bioresorbable polymers in the European region is primarily due to the increasing prevalence of chronic diseases such as cancers, cardiovascular diseases, orthopedic disorders, and neurological conditions. Bariatric, trauma, orthopedic, and cardiovascular surgical procedures are also on the rise in Europe. The region has developed a strong health care infrastructure and increased the level of advanced medical research further, which has clearly enhanced this market for bioresorbable polymers offered as sustainable and biocompatible solutions for implants and drug delivery systems. Additionally, the support by regulatory towards biodegradable material-based medical devices helps to spread across the European market.

• By Company Type: Tier 1 – 55%, Tier 2 – 25%, and Tier 3 – 20%
• By Designation: Directors – 50%, Managers – 30%, and Others – 20%
• By Region: North America – 40%, Europe – 35%, Asia Pacific – 20%, Rest of World – 5%

The key players profiled in the report include Corbion (Netherlands), Evonik Industries AG (Germany), Foster Corporation (US), KLS Martin Group (Germany), DSM Biomedical (US), Ashland Global Holdings Inc. (US), Zeus Company LLC (US), Seqens (France), Reva Medical, LLC (US), and Poly-Med Incorporated (US).

Research Coverage

This report segments the market for bioresorbable polymers based on type, application, and region and provides estimations of value (USD Million) for the overall market size across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, services, and key strategies, associated with the market for bioresorbable polymers.

Reasons to Buy this Report

This research report is focused on various levels of analysis — industry analysis (industry trends), market share analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the bioresorbable polymers market; high-growth regions; and market drivers, restraints, and opportunities.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on bioresorbable polymers offered by top players in the global market
• Analysis of key drivers: (Increasing number of surgical interventions, Boost in demand of biocompatible medical devices, Growing demand in drug delivery application, Favorable reimbursement scenario), opportunities (Electrospinning and 3D Printing Technologies), and challenges (Stringent regulatory framework for medical devices)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the bioresorbable polymers market
• Market Development: Comprehensive information about lucrative emerging markets — the report analyzes the markets for bioresorbable polymers across regions.
• Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global bioresorbable polymers market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the bioresorbable polymers market

Table of Contents

1               INTRODUCTION              23

1.1           STUDY OBJECTIVES       23

1.2           MARKET DEFINITION   23

1.3           STUDY SCOPE   24

1.3.1        MARKETS COVERED       24

1.3.2        INCLUSIONS AND EXCLUSIONS 25

1.3.3        DEFINITION AND INCLUSIONS, BY TYPE               25

1.3.4        DEFINITION AND INCLUSIONS, BY APPLICATION                 26

1.3.5        YEARS CONSIDERED      27

1.3.6        CURRENCY CONSIDERED            27

1.3.7        UNITS CONSIDERED      27

1.4           STAKEHOLDERS               28

1.5           SUMMARY OF CHANGES               28

2               RESEARCH METHODOLOGY       29

2.1           RESEARCH DATA              29

2.1.1        SECONDARY DATA          30

2.1.1.1    Key data from secondary sources       30

2.1.2        PRIMARY DATA 30

2.1.2.1    Interviews with experts – demand and supply sides        31

2.1.2.2    Key data from primary sources           31

2.1.2.3    Key industry insights           32

2.1.2.4    Breakdown of interviews with experts               32

2.2           MARKET SIZE ESTIMATION         33

2.2.1        TOP-DOWN APPROACH                33

2.2.2        BOTTOM-UP APPROACH              35

2.3           GROWTH FORECAST      36

2.3.1        SUPPLY-SIDE FORECAST               36

2.3.2        DEMAND-SIDE FORECAST           36

2.4           FACTOR ANALYSIS          37

2.5           DATA TRIANGULATION                38

2.6           RESEARCH ASSUMPTIONS           40

2.7           RESEARCH LIMITATIONS             40

2.8           RISK ASSESSMENT           41

3               EXECUTIVE SUMMARY  42

4               PREMIUM INSIGHTS       46

4.1           SIGNIFICANT OPPORTUNITIES FOR PLAYERS IN BIORESORBABLE POLYMERS MARKET   46

4.2           BIORESORBABLE POLYMERS MARKET, BY REGION                 46

4.3           NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE AND COUNTRY           47

4.4           BIORESORBABLE POLYMERS MARKET, BY APPLICATION AND REGION       47

4.5           BIORESORBABLE POLYMERS MARKET ATTRACTIVENESS           48

5               MARKET OVERVIEW       49

5.1           INTRODUCTION              49

5.2           MARKET DYNAMICS       49

5.2.1        DRIVERS               50

5.2.1.1    Increasing number of surgical interventions    50

5.2.1.2    Rising demand for biocompatible medical devices          50

5.2.1.3    Growing demand for drug delivery applications              50

5.2.1.4    Favorable reimbursement scenario    51

5.2.2        RESTRAINTS      52

5.2.2.1    Increasing preference for minimally invasive surgeries  52

5.2.2.2    Higher cost of bioresorbable polymers than conventional polymers 52

5.2.2.3    Lack of quality control measures in emerging countries                 53

5.2.3        OPPORTUNITIES              53

5.2.3.1    Electrospinning and 3D printing technologies                 53

5.2.4        CHALLENGES    54

5.2.4.1    Stringent regulatory framework for medical devices       54

5.2.4.2    Requirement of skilled personnel for effective use of bioresorbable medical products          54

5.3           PORTER’S FIVE FORCES ANALYSIS           54

5.3.1        THREAT OF NEW ENTRANTS      56

5.3.2        THREAT OF SUBSTITUTES          56

5.3.3        BARGAINING POWER OF SUPPLIERS       56

5.3.4        BARGAINING POWER OF BUYERS             56

5.3.5        INTENSITY OF COMPETITIVE RIVALRY 57

5.4           KEY STAKEHOLDERS AND BUYING CRITERIA     57

5.4.1        KEY STAKEHOLDERS IN BUYING PROCESS           57

5.4.2        BUYING CRITERIA           58

5.5           MACROECONOMIC INDICATORS              59

5.5.1        GDP TRENDS AND FORECAST OF MOST PROMINENT ECONOMIES      59

6               INDUSTRY TRENDS         60

6.1           SUPPLY CHAIN ANALYSIS             60

6.1.1        RAW MATERIAL SUPPLIERS         60

6.1.2        MANUFACTURERS           61

6.1.3        DISTRIBUTORS 61

6.1.4        END-USE INDUSTRIES   61

6.2           PRICING ANALYSIS          61

6.2.1        AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION   61

6.2.2        AVERAGE SELLING PRICE TREND, BY REGION   62

6.3           TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS            63

6.4           ECOSYSTEM ANALYSIS  64

6.5           TECHNOLOGY ANALYSIS             66

6.5.1        KEY TECHNOLOGIES     66

6.5.1.1    Electrospinning technology in bioresorbable polymers  66

6.5.2        COMPLEMENTARY TECHNOLOGIES       66

6.5.2.1    Melt extrusion technology  66

6.6           CASE STUDY ANALYSIS 67

6.6.1        BIORESORBABLE POLYMER SCAFFOLDS FOR TISSUE ENGINEERING  67

6.6.2        BIORESORBABLE MATERIALS FOR CARDIOVASCULAR DEVICES              67

6.6.3        BIORESORBABLE 3D-PRINTED PATIENT-SPECIFIC IMPLANTS FOR CRANIO-MAXILLOFACIAL SURGERY       68

6.7           TRADE ANALYSIS             68

6.7.1        IMPORT SCENARIO (HS CODE 390770)    68

6.7.2        EXPORT SCENARIO (HS CODE 390770)    69

6.8           REGULATORY LANDSCAPE         70

6.8.1        REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS             71

6.8.2        REGULATORY FRAMEWORK       74

6.8.2.1    Regulations impacting bioresorbable polymers business                 74

6.8.2.2    FDA guidelines for bioabsorbable polymers in medical devices                 74

6.8.2.3    REACH (Registration, evaluation, authorization and restriction of chemicals)         74

6.8.2.4    ISO 10993 (Biological evaluation of medical devices)   75

6.8.2.5    EU medical device regulation (MDR) for bioresorbable polymers                 75

6.8.2.6    ASTM standards for absorbable polymers and implants                 75

6.9           KEY CONFERENCES AND EVENTS, 2024–2025        75

6.10         INVESTMENT AND FUNDING SCENARIO               76

6.11         PATENT ANALYSIS          76

6.11.1      APPROACH         76

6.11.2      PATENT TYPES 76

6.11.3      TOP APPLICANTS            79

6.11.4      JURISDICTION ANALYSIS              82

6.12         IMPACT OF AI/GEN AI ON BIORESORBABLE POLYMERS MARKET               82

7               BIORESORBABLE POLYMERS MARKET, BY TYPE                 83

7.1           INTRODUCTION              84

7.2           POLYLACTIC ACID (PLA)              86

7.2.1        RISING DEMAND FOR ORTHOPEDIC DEVICES TO DRIVE MARKET               86

7.3           POLYGLYCOLIC ACID (PGA)       88

7.3.1        USE IN SUTURES AND OTHER MEDICAL IMPLANTS TO PROPEL MARKET             88

7.4           POLY (LACTIC-CO-GLYCOLIC ACID) (PLGA)       90

7.4.1        BIOCOMPATIBILITY AND BIODEGRADABILITY TO DRIVE MARKET 90

7.5           POLYCAPROLACTONE (PCL)      93

7.5.1        DRUG DELIVERY, TISSUE ENGINEERING, AND ORTHOPEDIC DEVICE APPLICATIONS TO DRIVE MARKET                 93

7.6           OTHER TYPES   95

8               BIORESORBABLE POLYMERS MARKET, BY APPLICATION   97

8.1           INTRODUCTION              98

8.2           ORTHOPEDIC DEVICES 100

8.2.1        HIGH CONSUMPTION IN NORTH AMERICA AND EUROPE TO DRIVE MARKET       100

8.3           DRUG DELIVERY              104

8.3.1        SIGNIFICANT DEMAND FOR ORAL CAPSULES TO DRIVE MARKET               104

8.4           OTHER APPLICATIONS 107

9               BIORESORBABLE POLYMERS MARKET, BY REGION                 110

9.1           INTRODUCTION              111

9.2           NORTH AMERICA             113

9.2.1        US           118

9.2.1.1    Growing demand for orthopedic devices and drug delivery applications to drive market                118

9.2.2        CANADA               120

9.2.2.1    Increasing geriatric population to boost demand            120

9.2.3        MEXICO                121

9.2.3.1    Rising medical tourism to propel market growth             121

9.3           ASIA PACIFIC     123

9.3.1        CHINA  128

9.3.1.1    Economic growth to be major driver for market growth                 128

9.3.2        JAPAN   130

9.3.2.1    Rapidly aging population to drive market         130

9.3.3        INDIA    131

9.3.3.1    Growing pharmaceutical and medical industries to drive market                 131

9.3.4        SOUTH KOREA  133

9.3.4.1    Increasing access to healthcare facilities to drive market                 133

9.4           EUROPE               135

9.4.1        GERMANY           140

9.4.1.1    Established healthcare industry and technological advancements offer opportunities for market growth               140

9.4.2        UK          142

9.4.2.1    Increasing healthcare expenditure to drive market growth                 142

9.4.3        ITALY    143

9.4.3.1    Orthopedic and pharmaceutical applications to propel market                 143

9.4.4        FRANCE                145

9.4.4.1    Initiatives to boost healthcare sector to drive demand   145

9.4.5        RUSSIA 146

9.4.5.1    Orthopedics, healthcare, and pharmaceutical segments contribute significantly to market growth         146

9.5           MIDDLE EAST & AFRICA                148

9.5.1        MIDDLE EAST   152

9.5.1.1    Improving healthcare infrastructure to drive market      152

9.5.2        AFRICA 154

9.5.2.1    South Africa to be largest market       154

9.6           SOUTH AMERICA             155

9.6.1        BRAZIL 159

9.6.1.1    Rising demand for implants in surgeries to drive market                 159

9.6.2        ARGENTINA       161

9.6.2.1    Investments by major players to drive market 161

10            COMPETITIVE LANDSCAPE         163

10.1         INTRODUCTION              163

10.2         KEY PLAYER STRATEGIES/RIGHT TO WIN            163

10.3         MARKET SHARE ANALYSIS           164

10.4         REVENUE ANALYSIS       166

10.5         COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023                 167

10.5.1      STARS   167

10.5.2      EMERGING LEADERS     167

10.5.3      PERVASIVE PLAYERS      167

10.5.4      PARTICIPANTS 167

10.5.5      COMPANY FOOTPRINT: KEY PLAYERS, 2023         169

10.5.5.1  Company footprint               169

10.5.5.2  Type footprint       170

10.5.5.3  Application footprint            171

10.5.5.4  Region footprint   172

10.6         COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023        173

10.6.1      PROGRESSIVE COMPANIES         173

10.6.2      RESPONSIVE COMPANIES            173

10.6.3      DYNAMIC COMPANIES  173

10.6.4      STARTING BLOCKS         173

10.6.5      COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023                 175

10.6.5.1  Detailed list of key startups/SMEs    175

10.6.5.2  Competitive benchmarking of key startups/SMEs          176

10.7         BRAND/PRODUCT COMPARISON             177

10.8         COMPANY VALUATION AND FINANCIAL METRICS                 178

10.9         COMPETITIVE SCENARIO             179

10.9.1      PRODUCT LAUNCHES   179

10.9.2      DEALS  180

10.9.3      EXPANSIONS     180

11            COMPANY PROFILES      182

11.1         KEY PLAYERS     182

11.1.1      CORBION             182

11.1.1.1  Business overview 182

11.1.1.2  Products/Solutions/Services offered 183

11.1.1.3  Recent developments           185

11.1.1.3.1                Deals      185

11.1.1.4  MnM view              185

11.1.1.4.1                Right to win           185

11.1.1.4.2                Strategic choices   185

11.1.1.4.3                Weaknesses and competitive threats 185

11.1.2      EVONIK INDUSTRIES AG               186

11.1.2.1  Business overview 186

11.1.2.2  Products/Solutions/Services offered 187

11.1.2.3  Recent developments           188

11.1.2.3.1                Expansions             188

11.1.2.3.2                Deals      188

11.1.2.4  MnM view              189

11.1.2.4.1                Right to win           189

11.1.2.4.2                Strategic choices   189

11.1.2.4.3                Weaknesses and competitive threats 189

11.1.3      FOSTER CORPORATION                190

11.1.3.1  Business overview 190

11.1.3.2  Products/Solutions/Services offered 190

11.1.3.3  MnM view              191

11.1.3.3.1                Right to win           191

11.1.3.3.2                Strategic choices   191

11.1.3.3.3                Weaknesses and competitive threats 191

11.1.4      KLS MARTIN GROUP      192

11.1.4.1  Business overview 192

11.1.4.2  Products/Solutions/Services offered 192

11.1.4.3  MnM view              193

11.1.4.3.1                Right to win           193

11.1.4.3.2                Strategic choices   193

11.1.4.3.3                Weaknesses and competitive threats 193

11.1.5      DSM BIOMEDICAL           194

11.1.5.1  Business overview 194

11.1.5.2  Products/Solutions/Services offered 194

11.1.5.3  MnM view              195

11.1.5.3.1                Right to win           195

11.1.5.3.2                Strategic choices   195

11.1.5.3.3                Weaknesses and competitive threats 195

11.1.6      ASHLAND GLOBAL HOLDINGS INC.        196

11.1.6.1  Business overview 196

11.1.6.2  Products/Solutions/Services offered 197

11.1.6.3  Recent developments           198

11.1.6.3.1                Product launches  198

11.1.6.3.2                Expansions             198

11.1.7      ZEUS COMPANY LLC      199

11.1.7.1  Business overview 199

11.1.7.2  Products/Solutions/Services offered 199

11.1.7.3  Recent developments           200

11.1.7.3.1                Product launches  200

11.1.8      SEQENS                201

11.1.8.1  Business overview 201

11.1.8.2  Products/Solutions/Services offered 201

11.1.9      REVA MEDICAL, LLC       202

11.1.9.1  Business overview 202

11.1.9.2  Products/Solutions/Services offered 202

11.1.10   POLY-MED INCORPORATED      203

11.1.10.1                 Business overview 203

11.1.10.2                 Products/Solutions/Services offered 203

11.2         OTHER PLAYERS              205

11.2.1      BEZWADA BIOMEDICAL, LLC     205

11.2.2      NOMISMA HEALTHCARE PVT. LTD.         206

11.2.3      BMG INC.             206

11.2.4      POLYSCIENCES, INC.      207

11.2.5      HUIZHOU FORYOU MEDICAL DEVICES CO., LTD.                 207

11.2.6      MUSASHINO CHEMICAL LABORATORY, LTD.     208

11.2.7    HENAN XINGHAN BIOLOGICAL TECHNOLOGY CO., LTD.                 209

12            ADJACENT AND RELATED MARKETS      210

12.1         INTRODUCTION              210

12.2         LIMITATIONS    210

12.3         POLY LACTIC ACID MARKET      210

12.3.1      MARKET DEFINITION   210

12.3.2      MARKET OVERVIEW       211

12.4         POLY LACTIC ACID MARKET, BY REGION             211

12.4.1      EUROPE               211

12.4.2      NORTH AMERICA             212

12.4.3      ASIA PACIFIC     213

12.4.4      SOUTH AMERICA             213

12.4.5      MIDDLE EAST & AFRICA                214

13            APPENDIX           215

13.1         DISCUSSION GUIDE        215

13.2         KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL                218

13.3         CUSTOMIZATION OPTIONS        220

13.4         RELATED REPORTS         220

13.5         AUTHOR DETAILS           221

LIST OF TABLES

TABLE 1                USD EXCHANGE RATES CONSIDERED, 2020–2023                 27

TABLE 2                BIORESORBABLE POLYMERS MARKET: RISK ASSESSMENT     41

TABLE 3                TOTAL EXPENDITURE ON HEALTH, BY COUNTRY, 2015–2021 (% OF GDP)             52

TABLE 4                BIORESORBABLE POLYMERS MARKET: PORTER’S FIVE FORCES ANALYSIS           55

TABLE 5                INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES (%)     57

TABLE 6                KEY BUYING CRITERIA FOR TOP THREE TYPES                 58

TABLE 7                GDP TRENDS AND FORECAST, BY KEY COUNTRY, 2021–2029 (USD BILLION)      59

TABLE 8                AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS OFFERED

BY KEY PLAYERS, BY APPLICATION, 2023 (USD/KG)         62

TABLE 9                AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS, BY REGION, 2021–2029 (USD/KG)                 63

TABLE 10              ROLES OF COMPANIES IN BIORESORBABLE POLYMERS ECOSYSTEM                65

TABLE 11              IMPORT DATA FOR HS CODE 390770-COMPLIANT PRODUCTS, BY REGION,

2019–2023 (USD THOUSAND)      69

TABLE 12              EXPORT DATA FOR HS CODE 390770-COMPLIANT PRODUCTS, BY REGION,

2019–2023 (USD THOUSAND)      70

TABLE 13              GLOBAL: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           71

TABLE 14              NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  72

TABLE 15              EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS           72

TABLE 16              ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 73

TABLE 17              SOUTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS                 73

TABLE 18              MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,

AND OTHER ORGANIZATIONS  74

TABLE 19              BIORESORBABLE POLYMERS: LIST OF KEY CONFERENCES AND EVENTS,

2024–2025              75

TABLE 20              BIORESORBABLE POLYMERS MARKET: FUNDING/INVESTMENT SCENARIO        76

TABLE 21              BIORESORBABLE POLYMERS MARKET: PATENT STATUS, 2014–2024           77

TABLE 22              LIST OF MAJOR PATENTS FOR BIORESORBABLE POLYMERS, 2014–2024     79

TABLE 23              PATENTS BY GORE & ASSOCIATES, 2014–2024                 80

TABLE 24              PATENTS BY KCI LICENSING INC., 2014–2024                 80

TABLE 25              PATENTS BY LOCKE CHRISTOPHER BRIAN, 2014–2024              80

TABLE 26              TOP 10 PATENT OWNERS IN US, 2014–2024                 81

TABLE 27              BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017–2022 (USD MILLION)            84

TABLE 28              BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023–2029 (USD MILLION)            85

TABLE 29              BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017–2022 (TON)               85

TABLE 30              BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023–2029 (TON)               86

TABLE 31              PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2017–2022 (USD MILLION)            87

TABLE 32              PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2023–2029 (USD MILLION)            87

TABLE 33              PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (TON)  87

TABLE 34              PLA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (TON)  88

TABLE 35              PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2017–2022 (USD MILLION)            89

TABLE 36              PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2023–2029 (USD MILLION)            89

TABLE 37              PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (TON)  90

TABLE 38              PGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (TON)  90

TABLE 39              PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2017–2022 (USD MILLION)            91

TABLE 40              PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2023–2029 (USD MILLION)            91

TABLE 41              PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2017–2022 (TON)               92

TABLE 42              PLGA-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2023–2029 (TON)               92

TABLE 43              PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2017–2022 (USD MILLION)            93

TABLE 44              PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION,

2023–2029 (USD MILLION)            94

TABLE 45              PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (TON)  94

TABLE 46              PCL-BASED BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (TON)  94

TABLE 47              OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION,

2017–2022 (USD MILLION)            95

TABLE 48              OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION,

2023–2029 (USD MILLION)            96

TABLE 49              OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION,

2017–2022 (TON)               96

TABLE 50              OTHER BIORESORBABLE POLYMER TYPES MARKET, BY REGION,

2023–2029 (TON)               96

TABLE 51              BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            98

TABLE 52              BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            99

TABLE 53              BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)                99

TABLE 54              BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)                99

TABLE 55              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES,

BY REGION, 2017–2022 (USD MILLION)   100

TABLE 56              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2023–2029 (USD MILLION)                 101

TABLE 57              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2017–2022 (TON)    101

TABLE 58              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY REGION, 2023–2029 (TON)    102

TABLE 59              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2017–2022 (USD MILLION)            102

TABLE 60              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2023–2029 (USD MILLION)            102

TABLE 61              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2017–2022 (TON)                 103

TABLE 62              BIORESORBABLE POLYMERS MARKET IN ORTHOPEDIC DEVICES, BY APPLICATION, 2023–2029 (TON)                 103

TABLE 63              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION,

2017–2022 (USD MILLION)            104

TABLE 64              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION,

2023–2029 (USD MILLION)            105

TABLE 65              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION,

2017–2022 (TON)               105

TABLE 66              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY REGION,

2023–2029 (TON)               106

TABLE 67              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2017–2022 (USD MILLION)                 106

TABLE 68              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2023–2029 (USD MILLION)                 106

TABLE 69              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2017–2022 (TON)   107

TABLE 70              BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY, BY APPLICATION, 2023–2029 (TON)   107

TABLE 71              BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2017–2022 (USD MILLION)                 108

TABLE 72              BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2023–2029 (USD MILLION)                 108

TABLE 73              BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2017–2022 (TON)     108

TABLE 74              BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS, BY REGION, 2023–2029 (TON)     109

TABLE 75              BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (USD MILLION)          111

TABLE 76              BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (USD MILLION)          112

TABLE 77              BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (TON)             112

TABLE 78              BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (TON)             113

TABLE 79              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (USD MILLION)            114

TABLE 80              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (USD MILLION)            115

TABLE 81              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (TON)               115

TABLE 82              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (TON)               115

TABLE 83              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            116

TABLE 84              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            116

TABLE 85              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               116

TABLE 86              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               117

TABLE 87              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (USD MILLION)            117

TABLE 88              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (USD MILLION)            117

TABLE 89              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (TON)               118

TABLE 90              NORTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (TON)               118

TABLE 91              US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            118

TABLE 92              US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            119

TABLE 93              US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)                119

TABLE 94              US: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)                119

TABLE 95             CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            120

TABLE 96             CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            120

TABLE 97             CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               121

TABLE 98             CANADA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               121

TABLE 99              MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            121

TABLE 100            MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            122

TABLE 101            MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               122

TABLE 102            MEXICO: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               122

TABLE 103            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (USD MILLION)            124

TABLE 104            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (USD MILLION)            124

TABLE 105            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017–2022 (TON)        124

TABLE 106            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023–2029 (TON)        125

TABLE 107            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            125

TABLE 108            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            125

TABLE 109            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               126

TABLE 110            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               126

TABLE 111            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (USD MILLION)            126

TABLE 112            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (USD MILLION)            127

TABLE 113            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (TON)               127

TABLE 114            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (TON)               128

TABLE 115            CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            128

TABLE 116            CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            129

TABLE 117            CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)          129

TABLE 118            CHINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)          129

TABLE 119            JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            130

TABLE 120            JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            130

TABLE 121            JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)          131

TABLE 122            JAPAN: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)          131

TABLE 123            INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            132

TABLE 124            INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            132

TABLE 125            INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)          133

TABLE 126            INDIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)          133

TABLE 127            SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            133

TABLE 128            SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            134

TABLE 129            SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               134

TABLE 130            SOUTH KOREA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               134

TABLE 131            EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (USD MILLION)            136

TABLE 132            EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (USD MILLION)            136

TABLE 133            EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2017–2022 (TON)            136

TABLE 134            EUROPE: BIORESORBABLE POLYMERS MARKET, BY TYPE, 2023–2029 (TON)            137

TABLE 135            EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            137

TABLE 136            EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            137

TABLE 137            EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               138

TABLE 138            EUROPE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               138

TABLE 139            EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (USD MILLION)            138

TABLE 140            EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (USD MILLION)            139

TABLE 141            EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2017–2022 (TON) 139

TABLE 142            EUROPE: BIORESORBABLE POLYMERS MARKET, BY COUNTRY, 2023–2029 (TON) 140

TABLE 143            GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            140

TABLE 144            GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            141

TABLE 145            GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               141

TABLE 146            GERMANY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               141

TABLE 147            UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            142

TABLE 148            UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            142

TABLE 149            UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)                143

TABLE 150            UK: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)                143

TABLE 151            ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            143

TABLE 152            ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            144

TABLE 153            ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)          144

TABLE 154            ITALY: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)          144

TABLE 155            FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            145

TABLE 156            FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            145

TABLE 157            FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               146

TABLE 158            FRANCE: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               146

TABLE 159            RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            146

TABLE 160            RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            147

TABLE 161            RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               147

TABLE 162            RUSSIA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               147

TABLE 163            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (USD MILLION)            148

TABLE 164            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (USD MILLION)            148

TABLE 165            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (TON)               149

TABLE 166            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (TON)               149

TABLE 167            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (USD MILLION)            149

TABLE 168            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (USD MILLION)            150

TABLE 169            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2017–2022 (TON)                 150

TABLE 170            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION, 2023–2029 (TON)                 150

TABLE 171            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (USD MILLION)                 151

TABLE 172            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (USD MILLION)                 151

TABLE 173            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2017–2022 (TON)          151

TABLE 174            MIDDLE EAST & AFRICA: BIORESORBABLE POLYMERS MARKET, BY REGION, 2023–2029 (TON)          152

TABLE 175            MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            152

TABLE 176            MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            152

TABLE 177            MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               153

TABLE 178            MIDDLE EAST: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               153

TABLE 179            AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            154

TABLE 180            AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            154

TABLE 181            AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               155

TABLE 182            AFRICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               155

TABLE 183            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (USD MILLION)            155

TABLE 184            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (USD MILLION)            156

TABLE 185            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2017–2022 (TON)               156

TABLE 186            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY TYPE,

2023–2029 (TON)               156

TABLE 187            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            157

TABLE 188            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            157

TABLE 189            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               157

TABLE 190            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               158

TABLE 191            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (USD MILLION)            158

TABLE 192            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (USD MILLION)            158

TABLE 193            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2017–2022 (TON)               159

TABLE 194            SOUTH AMERICA: BIORESORBABLE POLYMERS MARKET, BY COUNTRY,

2023–2029 (TON)               159

TABLE 195            BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            159

TABLE 196            BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            160

TABLE 197            BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               160

TABLE 198            BRAZIL: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               160

TABLE 199            ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (USD MILLION)            161

TABLE 200            ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (USD MILLION)            161

TABLE 201            ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2017–2022 (TON)               161

TABLE 202            ARGENTINA: BIORESORBABLE POLYMERS MARKET, BY APPLICATION,

2023–2029 (TON)               162

TABLE 203            BIORESORBABLE POLYMERS MARKET: OVERVIEW OF MAJOR STRATEGIES ADOPTED BY KEY PLAYERS, 2019–2024              163

TABLE 204            BIORESORBABLE POLYMERS MARKET: DEGREE OF COMPETITION, 2023                 164

TABLE 205            BIORESORBABLE POLYMERS MARKET: TYPE FOOTPRINT       170

TABLE 206            BIORESORBABLE POLYMERS MARKET: APPLICATION FOOTPRINT         171

TABLE 207            BIORESORBABLE POLYMERS MARKET: REGION FOOTPRINT       172

TABLE 208            BIORESORBABLE POLYMERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES             175

TABLE 209            BIORESORBABLE POLYMERS MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES                 176

TABLE 210            BIORESORBABLE POLYMERS MARKET: PRODUCT LAUNCHES,

JANUARY 2020– OCTOBER 2024  179

TABLE 211            BIORESORBABLE POLYMERS MARKET: DEALS, JANUARY 2020–OCTOBER 2024   180

TABLE 212            BIORESORBABLE POLYMERS MARKET: EXPANSIONS, JANUARY 2020–

OCTOBER 2024  181

TABLE 213            CORBION: COMPANY OVERVIEW             182

TABLE 214            CORBION: PRODUCTS/SOLUTIONS/SERVICES OFFERED             183

TABLE 215            CORBION: DEALS, JANUARY 2020–OCTOBER 2024        185

TABLE 216            EVONIK INDUSTRIES AG: COMPANY OVERVIEW                 186

TABLE 217            EVONIK INDUSTRIES AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED    187

TABLE 218            EVONIK INDUSTRIES AG: EXPANSIONS, JANUARY 2020–OCTOBER 2024   188

TABLE 219            EVONIK INDUSTRIES AG: DEALS, JANUARY 2020–OCTOBER 2024  188

TABLE 220            FOSTER CORPORATION: COMPANY OVERVIEW                 190

TABLE 221            FOSTER CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED    190

TABLE 222            KLS MARTIN GROUP: COMPANY OVERVIEW                 192

TABLE 223            KLS MARTIN GROUP: PRODUCTS/SOLUTIONS/SERVICES OFFERED    192

TABLE 224            DSM BIOMEDICAL: COMPANY OVERVIEW                 194

TABLE 225            DSM BIOMEDICAL: PRODUCTS/SOLUTIONS/SERVICES OFFERED    194

TABLE 226            ASHLAND GLOBAL HOLDINGS INC.: COMPANY OVERVIEW          196

TABLE 227            ASHLAND GLOBAL HOLDINGS INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED    197

TABLE 228            ASHLAND GLOBAL HOLDINGS INC.: PRODUCT LAUNCHES, JANUARY 2020– OCTOBER 2024          198

TABLE 229            ASHLAND GLOBAL HOLDINGS INC.: EXPANSIONS, JANUARY 2020–OCTOBER 2024       198

TABLE 230            ZEUS COMPANY LLC: COMPANY OVERVIEW                 199

TABLE 231            ZEUS COMPANY LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    199

TABLE 232            ZEUS COMPANY LLC: PRODUCT LAUNCHES, JANUARY 2020–OCTOBER 2024   200

TABLE 233            SEQENS: COMPANY OVERVIEW 201

TABLE 234            SEQENS: PRODUCTS/SOLUTIONS/SERVICES OFFERED             201

TABLE 235            REVA MEDICAL, LLC: COMPANY OVERVIEW                 202

TABLE 236            REVA MEDICAL, LLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED    202

TABLE 237            POLY-MED INCORPORATED: COMPANY OVERVIEW          203

TABLE 238            POLY-MED INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED    203

TABLE 239            BEZWADA BIOMEDICAL, LLC: COMPANY OVERVIEW          205

TABLE 240            NOMISMA HEALTHCARE PVT. LTD.: COMPANY OVERVIEW          206

TABLE 241            BMG INC.: COMPANY OVERVIEW              206

TABLE 242            POLYSCIENCES, INC.: COMPANY OVERVIEW                 207

TABLE 243            HUIZHOU FORYOU MEDICAL DEVICES CO., LTD.: COMPANY OVERVIEW       207

TABLE 244            MUSASHINO CHEMICAL LABORATORY, LTD.: COMPANY OVERVIEW   208

TABLE 245            HENAN XINGHAN BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW              209

TABLE 246            POLY LACTIC ACID MARKET, BY REGION, 2019–2022 (USD MILLION)       211

TABLE 247            POLY LACTIC ACID MARKET, BY REGION, 2023–2028 (USD MILLION)       211

TABLE 248            EUROPE: POLY LACTIC ACID MARKET, BY COUNTRY, 2019–2022 (USD MILLION)     211

TABLE 249            EUROPE: POLY LACTIC ACID MARKET, BY COUNTRY, 2023–2028 (USD MILLION)     212

TABLE 250            NORTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY,

2019–2022 (USD MILLION)            212

TABLE 251            NORTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY,

2023–2028 (USD MILLION)            212

TABLE 252            ASIA PACIFIC: POLY LACTIC ACID MARKET, BY COUNTRY,

2019–2022 (USD MILLION)            213

TABLE 253            ASIA PACIFIC: POLY LACTIC ACID MARKET, BY COUNTRY,

2023–2028 (USD MILLION)            213

TABLE 254            SOUTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY,

2019–2022 (USD MILLION)            213

TABLE 255            SOUTH AMERICA: POLY LACTIC ACID MARKET, BY COUNTRY,

2023–2028 (USD MILLION)            213

TABLE 256            MIDDLE EAST & AFRICA: POLY LACTIC ACID MARKET, BY COUNTRY,

2019–2022 (USD MILLION)            214

TABLE 257            MIDDLE EAST & AFRICA: POLY LACTIC ACID MARKET, BY COUNTRY,

2023–2028 (USD MILLION)            214

LIST OF FIGURES

FIGURE 1              BIORESORBABLE POLYMERS MARKET SEGMENTATION AND REGIONAL SCOPE              24

FIGURE 2              BIORESORBABLE POLYMERS MARKET: RESEARCH DESIGN         29

FIGURE 3              APPROACH FOR BASE MARKET CALCULATION AND VALIDATION           33

FIGURE 4              MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 1 (TOP-DOWN)         34

FIGURE 5              MARKET SIZE ESTIMATION METHODOLOGY: APPROACH 2 (SUPPLY SIDE)      35

FIGURE 6              BIORESORBABLE POLYMERS MARKET: SUPPLY-SIDE FORECAST                36

FIGURE 7              MARKET GROWTH PROJECTIONS FROM DEMAND-SIDE DRIVERS AND OPPORTUNITIES 37

FIGURE 8              FACTOR ANALYSIS OF BIORESORBABLE POLYMERS MARKET       37

FIGURE 9              BIORESORBABLE POLYMERS MARKET: DATA TRIANGULATION             39

FIGURE 10            PLA TO BE LARGEST BIORESORBABLE POLYMER TYPE DURING FORECAST PERIOD     43

FIGURE 11            DRUG DELIVERY TO BE FASTEST-GROWING APPLICATION OF BIORESORBABLE POLYMERS DURING FORECAST PERIOD         43

FIGURE 12            NORTH AMERICA ACCOUNTED FOR LARGEST SHARE OF BIORESORBABLE POLYMERS MARKET IN 2023                 44

FIGURE 13            HIGH MARKET GROWTH EXPECTED IN EMERGING ECONOMIES DURING

FORECAST PERIOD         46

FIGURE 14            NORTH AMERICA TO BE LARGEST BIORESORBABLE POLYMERS MARKET

DURING FORECAST PERIOD       46

FIGURE 15            US ACCOUNTED FOR LARGEST MARKET SHARE IN NORTH AMERICA       47

FIGURE 16            ORTHOPEDIC DEVICES SEGMENT TO DOMINATE BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD         47

FIGURE 17            INDIA TO BE FASTEST-GROWING BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD                48

FIGURE 18            DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN BIORESORBABLE POLYMERS MARKET 49

FIGURE 19            PHARMACEUTICAL R&D EXPENDITURE IN EUROPE, US, JAPAN, AND CHINA,

2000–2022 (USD MILLION)            51

FIGURE 20            BIORESORBABLE POLYMERS MARKET: PORTER’S FIVE FORCES ANALYSIS           55

FIGURE 21            INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES             57

FIGURE 22            KEY BUYING CRITERIA, BY TOP THREE TYPES                 58

FIGURE 23            BIORESORBABLE POLYMERS MARKET: SUPPLY CHAIN ANALYSIS              60

FIGURE 24            AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS OFFERED

BY KEY PLAYERS, BY APPLICATION, 2023 (USD/KG)         62

FIGURE 25            AVERAGE SELLING PRICE TREND OF BIORESORBABLE POLYMERS, BY REGION, 2021–2029 (USD/KG)                 63

FIGURE 26            TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS   64

FIGURE 27            BIORESORBABLE POLYMERS MARKET: ECOSYSTEM ANALYSIS  64

FIGURE 28            IMPORT DATA RELATED TO HS CODE 390770-COMPLIANT PRODUCTS,

BY KEY COUNTRY, 2019–2023 (USD THOUSAND)                69

FIGURE 29            EXPORT DATA RELATED TO HS CODE 390770-COMPLIANT PRODUCTS,

BY KEY COUNTRY, 2019–2023 (USD THOUSAND)                70

FIGURE 30            REGISTERED PATENTS RELATED TO BIORESORBABLE POLYMERS, 2014–2024 77

FIGURE 31            TOP PATENT OWNERS DURING LAST 10 YEARS, 2014–2024              78

FIGURE 32            LEGAL STATUS OF PATENTS FILED FOR BIORESORBABLE POLYMERS, 2014–2024 81

FIGURE 33           MAXIMUM PATENTS FILED IN US JURISDICTION, 2014–2024              82

FIGURE 34            PLGA TO BE FASTEST-GROWING SEGMENT DURING FORECAST PERIOD       84

FIGURE 35            ASIA PACIFIC TO BE FASTEST-GROWING BIORESORBABLE POLYMERS MARKET FOR PLA SEGMENT                 86

FIGURE 36            NORTH AMERICA TO BE LARGEST PGA-BASED BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD                88

FIGURE 37            ASIA PACIFIC TO BE FASTEST-GROWING PLGA-BASED BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD         91

FIGURE 38            EUROPE TO BE SECOND-LARGEST MARKET FOR PCL-BASED BIORESORBABLE POLYMERS BETWEEN 2024 AND 2029              93

FIGURE 39            ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR OTHER BIORESORBABLE POLYMER TYPES DURING FORECAST PERIOD       95

FIGURE 40            ORTHOPEDIC DEVICES TO BE LARGEST APPLICATION OF BIORESORBABLE POLYMERS DURING FORECAST PERIOD         98

FIGURE 41            NORTH AMERICA TO BE LARGEST MARKET FOR BIORESORBABLE POLYMERS IN ORTHOPEDIC DEVICES APPLICATION   100

FIGURE 42            NORTH AMERICA TO BE LARGEST BIORESORBABLE POLYMERS MARKET IN DRUG DELIVERY APPLICATION   104

FIGURE 43            EUROPE TO BE SECOND-LARGEST BIORESORBABLE POLYMERS MARKET IN OTHER APPLICATIONS 107

FIGURE 44            ASIA PACIFIC TO BE FASTEST-GROWING BIORESORBABLE POLYMERS MARKET DURING FORECAST PERIOD                111

FIGURE 45            NORTH AMERICA: BIORESORBABLE POLYMERS MARKET SNAPSHOT       114

FIGURE 46            ASIA PACIFIC: BIORESORBABLE POLYMERS MARKET SNAPSHOT       123

FIGURE 47            EUROPE: BIORESORBABLE POLYMERS MARKET SNAPSHOT          135

FIGURE 48            BIORESORBABLE POLYMERS MARKET SHARE ANALYSIS, 2023  165

FIGURE 49            BIORESORBABLE POLYMERS MARKET: REVENUE ANALYSIS OF KEY PLAYERS

(USD MILLION), 2019–2023            166

FIGURE 50            BIORESORBABLE POLYMERS MARKET: COMPANY EVALUATION MATRIX,

KEY PLAYERS, 2023           168

FIGURE 51            BIORESORBABLE POLYMERS MARKET: COMPANY FOOTPRINT 169

FIGURE 52            BIORESORBABLE POLYMERS MARKET: COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023                 174

FIGURE 53            BIORESORBABLE POLYMERS MARKET: BRAND/PRODUCT COMPARISON             177

FIGURE 54            BIORESORBABLE POLYMERS MARKET: EV/EBITDA OF KEY MANUFACTURERS  178

FIGURE 55            BIORESORBABLE POLYMERS MARKET: ENTERPRISE VALUATION OF KEY PLAYERS (USD BILLION)                 179

FIGURE 56            CORBION: COMPANY SNAPSHOT             183

FIGURE 57            EVONIK INDUSTRIES AG: COMPANY SNAPSHOT                 187

FIGURE 58            ASHLAND GLOBAL HOLDINGS INC.: COMPANY SNAPSHOT          197

MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。

※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。

ライセンス別価格表

調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。

ライセンスタイプ1

ライセンスタイプ2

ライセンスタイプ3

ライセンスタイプ4

ミニレポート　※定性調査にフォーカスした調査レポートです。詳細はお問合せください。

ご購入に関するご案内

価格・納期について

• 価格
  • ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
• ライセンス
  • シングルユーザライセンス
    • 1名のみレポートファイルのご利用が可能です。
  • マルチユーザライセンス
    • 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
  • コーポレートライセンス
    • 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
  • エンタープライズサイトライセンス
    • 特別ライセンスです。適用範囲についてはお問合せください。
• 納品形態
  • Eメール
• 納期
  • 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）

ご注文方法

• レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。

その他

• 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。

株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。

最新調査レポート

• 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
• 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
• 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
• ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11

MarketsandMarkets  出版レポート一覧